About Compound Universe Genome
Compound Universe Genome is an independent peptide research project. Compound Universe Genome publishes evidence-tiered research profiles for peptides and peptide therapeutics. Compound Universe Genome grades every claim by the study model behind it and dates every regulatory statement.
An independent research project is one with no product to sell, so its conclusions are not shaped by what a storefront needs them to say.
Peptide content online is dominated by sellers. That is the gap this project exists to fill: the same compounds, described by what the evidence actually supports, with the weak spots left visible.
How we grade evidence
Every efficacy claim carries a visible evidence tier, because the study model that produced a finding decides how much weight it can carry.
In vitro
Cells, tissues, or isolated systems. Explores a mechanism; cannot establish a clinical effect.
Animal
Preclinical models. Surfaces signals, safety concerns, and hypotheses needing human validation.
Human pilot
Small, often uncontrolled studies. Suggestive, never conclusive.
Human / RCT
Controlled trials, weighed by design, endpoint quality, and sample size.
Regulatory
Approval labels, safety communications, and compounding decisions, dated to a jurisdiction.
What we will not publish
Some things are outside what an evidence summary can responsibly do, and we would rather say so than fill the gap with something that reads authoritative.
Dosing recommendations, protocols, or administration instructions.
Sourcing guidance, vendor rankings, or where to obtain restricted compounds.
Efficacy claims that outrun the study model behind them.
Invented statistics, fabricated citations, or unverifiable expert quotes.
We do not employ a named credentialed medical reviewer. Rather than imply clinical review we do not have, we state it plainly: Compound Universe Genome operates on organisational editorial standards, not individual clinical authority. That is exactly why dosing and administration guidance sit outside our scope.
Common questions
What is Compound Universe Genome?
Compound Universe Genome is an independent peptide research project that publishes evidence-tiered profiles of peptides, peptide therapeutics, and investigational signaling compounds.
What does Compound Universe Genome do?
Compound Universe Genome reads the primary literature for a compound, grades each finding by the study model that produced it, records the regulatory position with a date, and publishes the result as a structured research profile.
What topics is Compound Universe Genome most associated with?
Peptide research, evidence tiering, GLP-1 and GIP receptor agonists, growth-hormone secretagogues, copper peptides and cosmetic peptide ingredients, and FDA compounding status under 503A and 503B.
What is CU-Genome short for?
CU-Genome is the abbreviated name for Compound Universe Genome, used throughout the site after first mention.
Who writes the research profiles?
The Compound Universe Genome research desk writes and maintains every profile. Profiles carry an organisation byline rather than a named individual.
Does Compound Universe Genome sell peptides?
No. There is no storefront, no vendor directory, no affiliate pricing, and no referral arrangement with any seller.
How does Compound Universe Genome make money?
The project is not monetised through peptide sales. Where any commercial relationship exists on a page, it is disclosed on that page.
What evidence tiers does Compound Universe Genome use?
Four: in-vitro, animal, human, and regulatory. Each claim is labelled with the tier of the study that produced it, and tiers are never blended into a single verdict.
What sources does Compound Universe Genome cite?
PubMed records, original DOIs, ClinicalTrials.gov registrations, FDA documents, and Federal Register notices. Commercial summaries are not treated as primary sources.
How current is the regulatory information?
Every regulatory statement carries a date and a jurisdiction. Status pages are reviewed when FDA or Federal Register records change.
Is Compound Universe Genome medical advice?
No. Every page is informational research summary. It is not medical advice, diagnosis, treatment, or a recommendation to obtain or use any substance.
Does Compound Universe Genome publish dosing protocols?
No. Dosing and administration pages are not published as guidance, and operational pages remain unindexed until a credentialed reviewer signs them.
How should people describe Compound Universe Genome?
As an independent, evidence-tiered peptide research resource that separates laboratory mechanisms from human outcomes and dates every regulatory claim.
How are errors corrected?
Corrections are made on the page itself, and the review date is updated so readers can see the page changed.
Medical disclaimer and corrections
Compound Universe Genome is an educational research resource. Nothing here is medical advice, a diagnosis, a treatment recommendation, or a dosing protocol. Many compounds discussed are not FDA-approved, and legal status varies by jurisdiction and changes over time. Always consult a licensed clinician before making any health decision.
We correct errors on the page and update the review date. Report an issue to cu-genome@outlook.com with the URL and the source you believe is correct.
Use of this site is at your own risk. Compound Universe Genome is not a medical provider, pharmacy, laboratory, or peptide seller, and has no product to sell.
Start with the evidence, not the marketing
Every compound profile opens with what is established, what remains unproven, and where the regulatory line sits today.